Left Atrial Appendage Closure: As Effective in Men and Women?

Atrial fibrillation is the most prevalent arrhythmia and to prevent its potential complications, we should administer anticoagulants (OACs), either warfarin or the new direct oral anticoagulants (DOACs). 

Cierre de orejuela de aurícula izquierda

Even though these drugs have been shown effective, they still involve the risk of bleeding, especially gastrointestinal bleeding, which in turn leads to numerous hospitalizations.

Left atrial appendage occlusion devices (LAAO) have been shown beneficial, even though in general terms they show similar outcomes to oral anticoagulants (OACs). At present, they are clearly recommended for patients who for whatever reason cannot be treated with OACs. 

There is little evidence looking at these benefits by sex.

This was a meta-analysis of the prospective EVOLUTION study, carried out in Europe in patients receiving the WATCHMAN in a “real world” context. The sample included 408 women and 612 men. 

Primary end point assessed the combination of mortality free survival, severe bleeding, ischemic stroke, TIA and systemic embolism over 2 years. 

Read also: Predictors and Evolution of Permanent Pacemaker After TAVR with Self-Expanding Valves.

Even though women were older (75 ± 9 vs. 73 ± 9 years, p < 0.001), they showed a lower incidence of peripheral vascular disease, hemorrhagic stroke and alcohol abuse. However, CHA2DS2‐VASc‐Score was superior (5 ± 1.5 vs. 4.1 ± 1.5, p < 0.001) and HAS‐BLED Score was comparable, with no difference in the rest of risk factors. 

During procedure, women showed better sealing vs. men (94% vs. 90%, p = 0.033), but presented higher incidence of pericardial effusion (1.2% vs. 0.2%, p = 0.031). Pericardial effusion and cardiac tamponade were rare, and similar between groups. 

After two years, there were no difference between men and women in primary end point (79% vs. 76%, p = 0.24) or survival (85% vs. 82%, p = 0.16).

Conclusion

Even though women undergoing LAAO differ in baseline characteristics, after adjusting for variables they showed similar safety and efficacy, with no significant differences at long term followup between men and women. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Sex‐related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.

Reference: Christina Paitazoglou, et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...